Federal contract award
75N94025F00003
NIDDK: SERVICE: INTRAVENOUS STABLE ISOTOPE GLUCOSE (6,6 DEUTERATED GLUCOSE) FOR METABOLIC RESEARCH. NONSEVERABLE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 75N94024D00003 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $69.5K |
| Current contract value | $69.5K |
| Potential contract value / ceiling | $69.5K |
| Start date | Aug 14, 2025 |
| Current end date | May 31, 2026 |
| Potential end date | May 31, 2026 |
| Latest award activity | Jan 16, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 16, 2026 | P00001 | $0 | NIDDK: SERVICE: INTRAVENOUS STABLE ISOTOPE GLUCOSE (6,6 DEUTERATED GLUCOSE) FOR METABOLIC RESEARCH. NONSEVERABLE |
| Aug 13, 2025 | 0 | $69.5K | NIDDK: SERVICE: INTRAVENOUS STABLE ISOTOPE GLUCOSE (6,6 DEUTERATED GLUCOSE) FOR METABOLIC RESEARCH. NONSEVERABLE |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.